MSVirtual2020
Home / Browse Library
  • Scientific Sessions

    Access to the MSVirtual2020 Scientific Program sessions.

    • Presentation Date(s):  Sept 11, 2020
    • Total Presentations: 165

Filter Results:

  • BD01 - DMTs prevent/slow down cognitive impairment in MS

    • Type: Burning Debate
    • Presentations: 2
    Chair(s): Dawn Langdon, Lauren Krupp
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    View Individual Presentation(s)
    • BD01.01 - DMTs prevent/slow down cognitive impairment in MS - Yes (View Presentation)

      Ralph Benedict

      • Presentation
    • BD01.02 - DMTs prevent/slow down cognitive impairment in MS - No (View Presentation)

      Christian Enzinger

      • Presentation
  • BD02 - DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity

    • Type: Burning Debate
    • Presentations: 2
    Chair(s): Mar Tintore, Robert Fox
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    View Individual Presentation(s)
    • BD02.01 - DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease avtivity - Yes (View Presentation)

      Rob Bermel

      • Presentation
    • BD02.02 - DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease avtivity - No (View Presentation)

      Patricia Coyle

      • Presentation
  • BD03 - Microglia are protective in MS

    • Type: Burning Debate
    • Presentations: 2
    Chair(s): Hans Lassmann, Oleg Butovsky
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    View Individual Presentation(s)
    • BD03.01 - Microglia are protective in MS - No (View Presentation)

      Tara Desilva

      • Presentation
    • BD03.02 - Microglia are protective in MS - Yes (View Presentation)

      Tuan Leng Tay

      • Presentation
  • MTE01 - CNS in disorders in children

    • Type: Meet the Expert
    • Presentations: 2
    Chair(s): Brenda Banwell, Tanuja Chitnis
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    View Individual Presentation(s)
    • MTE01.01 - CNS disorders in children (View Presentation)

      Tanuja Chitnis

      • Presentation
    • MTE01.02 - Diagnosis and management of MOG-AD (View Presentation)

      Brenda Banwell

      • Presentation
  • MTE02 - Neuro-ophthalmology of MS

    • Type: Meet the Expert
    • Presentations: 1
    Chair(s): Ari Green
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    • MTE02.01 - Neuro-ophthalmology of MS (View Presentation)

      Ari Green

      • Presentation
  • MTE03 - B-cell-directed therapy in MS

    • Type: Meet the Expert
    • Presentations: 2
    Chair(s): Anne Cross, Fredrik Piehl
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    View Individual Presentation(s)
    • MTE03.01 - Anti-CD20 therapies in MS - clinical trial data, changes in CSF, and proposed mechanisms of action (View Presentation)

      Anne Cross

      • Presentation
    • MTE03.02 - B-cell-directed therapy in MS - practical implications and effectiveness and safety in clinical practice (View Presentation)

      Fredrik Piehl

      • Presentation
  • MTE04 - Choosing the right MS disease therapy for individual patients

    • Type: Meet the Expert
    • Presentations: 1
    Chair(s): Mar Tintore, Antonio Uccelli
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    • MTE04.01 - Choosing the right MS disease therapy for individual patients (View Presentation)

      Mar Tintore, Antonio Uccelli

      • Presentation
  • MTE05 - Immune disorders of the CNS other than MS

    • Type: Meet the Expert
    • Presentations: 1
    Chair(s): Aksel Siva, Dean Wingerchuk
    Presented on: 9/11/2020, 08:00
    WATCH SESSION
    • MTE05.01 - Immune-mediated disorders of the CNS other than MS (View Presentation)

      Aksel Siva, Dean Wingerchuk

      • Presentation
  • PL01 - Plenary Session 1: Welcome and Paty Lecture

    • Type: Plenary Session
    • Presentations: 1
    Presented on: 9/11/2020, 09:00
    WATCH SESSION
    • PL01.01 - The MS Prodrome (View Presentation)

      Helen Tremlett

      • Presentation
  • PS01 - Strategies for disease modification

    • Type: Parallel Session
    • Track: Clinical
    • Presentations: 5
    Chair(s): Eva Kubala Havrdov√°, Daniel Ontaneda
    Presented on: 9/11/2020, 10:15
    WATCH SESSION
    View Individual Presentation(s)
    • PS01.01 - Escalation versus aggressive treatment algorithms (View Presentation)

      Ellen Mowry

      • Presentation
    • PS01.02 - When is it appropriate to discontinue DMT? (View Presentation)

      John Corboy

      • Presentation
    • PS01.03 - Management of RIS (View Presentation)

      Christine Lebrun-Frenay

      • Presentation
    • PS01.04 - Comparison of disability trajectories in relapsing Multiple Sclerosis patients treated with early intensive or escalation treatment strategies (View Presentation)

      Keyword: Observational Studies

      Pietro Iaffaldano

      • Presentation
    • PS01.05 - Rituximab treatment for MS: an observational multicentric dose comparison (View Presentation)

      Keyword: Disease Modifying Therapies - Risk Management

      Luciana Midaglia

      • Presentation